MAPK phosphorylation of connexin 43 promotes binding of cyclin e and smooth muscle cell proliferation

Circulation Research

Volumn 111, Issue 2, 2012, Pages 201-211

  Johnstone, Scott R ^a   Kroncke, Brett M ^a   Straub, Adam C ^a   Best, Angela K ^a   Dunn, Clarence A ^b   Mitchell, Leslie A ^c   Peskova, Yelena ^a   Nakamoto, Robert K ^a   Koval, Michael ^c   Lo, Cecilia W ^d   Lampe, Paul D ^b   Columbus, Linda ^a   Isakson, Brant E ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

atherogenesis; connexin 43; neointima; phosphorylation; platelet derived growth factor; proliferation; vascular smooth muscle cells

Indexed keywords

ALANINE; APOLIPOPROTEIN E; ASPARTIC ACID; CONNEXIN 43; CYCLIN DEPENDENT KINASE 2; CYCLIN E; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR BB; SERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CAROTID ARTERY; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE MUTATION; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE CELL; WILD TYPE;

ANIMALS; ANIMALS, NEWBORN; ATHEROSCLEROSIS; CELL PROLIFERATION; CONNEXIN 43; CYCLIN E; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PROTEIN BINDING;

EID: 84863727283     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.272302     Document Type: Article

References (57)

1. Ross R, Glomset JA. Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science. 1973;180:1332-1339.
2. Rekhter MD, Gordon D. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol. 1995;147:668-677.
3. Manolakou P, Angelopoulou R, Bakoyiannis C, Psathas E, Bastounis E, Kavantzas N, Patsouris E. Cellular proliferation in complicated versus uncomplicated atherosclerotic lesions: total cell population, foam cells and newly formed microvessels. Tissue Cell. 2009;41:408-413.
4. Li L, Blumenthal DK, Terry CM, He Y, Carlson ML, Cheung AK. PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms. J Cell Biochem. 2010;112:289-298.
5. Keramati AR, Singh R, Lin A, Faramarzi S, Ye ZJ, Mane S, Tellides G, Lifton RP, Mani A. Wild-type lrp6 inhibits, whereas atherosclerosislinked lrp6r611c increases PDGF-dependent vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA. 2011;108:1914-1918.
6. Fuster JJ, Fernandez P, Gonzalez-Navarro H, Silvestre C, Nabah YN, Andres V. Control of cell proliferation in atherosclerosis: insights from animal models and human studies. Cardiovasc Res. 2009;86:254-264.
7. Vukovic I, Arsenijevic N, Lackovic V, Todorovic V. The origin and differentiation potential of smooth muscle cells in coronary atherosclerosis. Exp Clin Cardiol. 2006;11:123-128. (Pubitemid 44018292)
8. Bhardwaj S, Roy H, Babu M, Shibuya M, Yla-Herttuala S. Adventitial gene transfer of VEGFr-2 specific VEGF-e chimera induces mcp-1 expression in vascular smooth muscle cells and enhances neointimal formation. Atherosclerosis. 2011;219:84-91.
9. Rosenfeld ME, Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1990;10:680-687. (Pubitemid 20273338)
10. Bentzon JF, Weile C, Sondergaard CS, Hindkjaer J, Kassem M, Falk E. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol. 2006;26:2696-2702.
11. Hoofnagle MH, Thomas JA, Wamhoff BR, Owens GK. Origin of neointimal smooth muscle: we've come full circle. Arterioscler Thromb Vasc Biol. 2006;26:2579-2581.
12. Johnstone SR, Ross J, Rizzo MJ, Straub AC, Lampe PD, Leitinger N, Isakson BE. Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferation. Am J Pathol. 2009;175:916-924.
13. Kwak BR, Mulhaupt F, Veillard N, Gros DB, Mach F. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2002;22:225-230. (Pubitemid 34127031)
14. Chadjichristos CE, Morel S, Derouette JP, Sutter E, Roth I, Brisset AC, Bochaton-Piallat ML, Kwak BR. Targeting connexin 43 prevents platelet-derived growth factor-bb-induced phenotypic change in porcine coronary artery smooth muscle cells. Circ Res. 2008;102:653-660. (Pubitemid 351457865)
15. Plenz G, Ko YS, Yeh HI, Eschert H, Sindermann JR, Dorszewski A, Hofnagel O, Robenek H, Breithardt G, Severs NJ. Upregulation of connexin43 gap junctions between neointimal smooth muscle cells. Eur J Cell Biol. 2004;83:521-530. (Pubitemid 40123817)
16. Yeh HI, Lupu F, Dupont E, Severs NJ. Upregulation of connexin43 gap junctions between smooth muscle cells after balloon catheter injury in the rat carotid artery. Arterioscler Thromb Vasc Biol. 1997;17:3174-3184. (Pubitemid 28016074)
17. Chadjichristos CE, Matter CM, Roth I, Sutter E, Pelli G, Luscher TF, Chanson M, Kwak BR. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation. 2006;113:2835-2843. (Pubitemid 44305296)
18. Plante I, Stewart MK, Barr K, Allan AL, Laird DW. Cx43 suppresses mammary tumor metastasis to the lung in a cx43 mutant mouse model of human disease. Oncogene. 2010;30:1681-1692.
19. Gellhaus A, Dong X, Propson S, Maass K, Klein-Hitpass L, Kibschull M, Traub O, Willecke K, Perbal B, Lye SJ, Winterhager E. Connexin43 interacts with Nov: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells. J Biol Chem. 2004;279:36931-36942. (Pubitemid 39129043)
20. Johnstone SR, Best AK, Wright CS, Isakson BE, Errington RJ, Martin PE. Enhanced connexin 43 expression delays intra-mitotic duration and cell cycle traverse independently of gap junction channel function. J Cell Biochem. 2010;110:772-782.
21. Zhang YW, Kaneda M, Morita I. The gap junction-independent tumorsuppressing effect of connexin 43. J Biol Chem. 2003;278:44852-44856. (Pubitemid 37377244)
22. Sun L, Zhang T, Yu X, Xin W, Lan X, Zhang D, Huang C, Du G. Asymmetric dimethylarginine confers the communication between endothelial and smooth muscle cells and leads to VSMC migration through p38 and erk1/2 signaling cascade. FEBS Lett. 2011;585:2727-2734.
23. Norris RP, Freudzon M, Mehlmann LM, Cowan AE, Simon AM, Paul DL, Lampe PD, Jaffe LA. Luteinizing hormone causes map kinasedependent phosphorylation and closure of connexin 43 gap junctions in mouse ovarian follicles: one of two paths to meiotic resumption. Development. 2008;135:3229-3238.
24. Marquez-Rosado L, Solan JL, Dunn CA, Norris RP, Lampe PD. Connexin43 phosphorylation in brain, cardiac, endothelial and epithelial tissues. Biochim Biophys Acta. 2012; In press.
25. Solan JL, Lampe PD. Key connexin 43 phosphorylation events regulate the gap junction life cycle. J Membr Biol. 2007;217:35-41. (Pubitemid 350160003)
26. Boassa D, Solan JL, Papas A, Thornton P, Lampe PD, Sosinsky GE. Trafficking and recycling of the connexin43 gap junction protein during mitosis. Traffic. 2010;11:1471-1486.
27. Solan JL, Lampe PD. Connexin43 phosphorylation: structural changes and biological effects. Biochem J. 2009;419:261-272.
28. Song GJ, Barrick S, Leslie KL, Bauer PM, Alonso V, Friedman PA, Fiaschi-Taesch NM, Bisello A. The scaffolding protein ebp50 promotes vascular smooth muscle cell proliferation and neointima formation by regulating skp2 and p21(cip1). Arterioscler Thromb Vasc Biol. 2011;32:33-41.
29. Chahine MN, Blackwood DP, Dibrov E, Richard MN, Pierce GN. Oxidized LDL affects smooth muscle cell growth through MAPK-mediated actions on nuclear protein import. J Mol Cell Cardiol. 2009;46:431-441.
30. Findeisen HM, Gizard F, Zhao Y, Qing H, Heywood EB, Jones KL, Cohn D, Bruemmer D. Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition. Arterioscler Thromb Vasc Biol. 2011;31:851-860.
31. Park ES, Yoo JM, Lim Y, Tudev M, Yoo HS, Hong JT, Yun YP. Inhibitory effects of docetaxel on platelet-derived growth factor (PDGF)-BB-induced proliferation of vascular smooth muscle cells through blocking PDGFreceptor beta phosphorylation. J Pharmacol Sci. 2011;116:204-213.
32. Tsaousi A, Williams H, Lyon CA, Taylor V, Swain A, Johnson JL, George SJ. Wnt4/beta-catenin signaling induces VSMC proliferation and is associated with intimal thickening. Circ Res. 2011;108:427-436.
33. Bedel A, Negre-Salvayre A, Heeneman S, Grazide MH, Thiers JC, Salvayre R, Maupas-Schwalm F. E-cadherin/beta-catenin/t-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein. Circ Res. 2008;103:694-701.
34. Gaulin JF, Fiset A, Fortier S, Faure RL. Characterization of cdk2-cyclin e complexes in plasma membrane and endosomes of liver parenchyma: insulin-dependent regulation. J Biol Chem. 2000;275:16658-16665. (Pubitemid 30398894)
35. Kisielewska J, Philipova R, Huang JY, Whitaker M. Map kinase dependent cycline/cdk2 activity promotes DNA replication in early sea urchin embryos. Dev Biol. 2009;334:383-394.
36. Guo J, Sheng G, Warner BW. Epidermal growth factor-induced rapid retinoblastoma phosphorylation at ser780 and ser795 is mediated by erk1/2 in small intestine epithelial cells. J Biol Chem. 2005;280:35992-35998. (Pubitemid 41633868)
37. De Donatis A, Comito G, Buricchi F, Vinci MC, Parenti A, Caselli A, Camici G, Manao G, Ramponi G, Cirri P. Proliferation versus migration in platelet-derived growth factor signaling: the key role of endocytosis. J Biol Chem. 2008;283:19948-19956.
38. Lee CK, Lee HM, Kim HJ, Park HJ, Won KJ, Roh HY, Choi WS, Jeon BH, Park TK, Kim B. Syk contributes to PDGF-BB-mediated migration of rat aortic smooth muscle cells via MAPK pathways. Cardiovasc Res. 2007;74:159-168. (Pubitemid 46366954)
39. Crespin S, Bechberger J, Mesnil M, Naus CC, Sin WC. The carboxy-terminal tail of connexin43 gap junction protein is sufficient to mediate cytoskeleton changes in human glioma cells. J Cell Biochem. 2010;110:589-597.
40. Dang X, Jeyaraman M, Kardami E. Regulation of connexin-43-mediated growth inhibition by a phosphorylatable amino-acid is independent of gap junction-forming ability. Mol Cell Biochem. 2006;289:201-207. (Pubitemid 44322490)
41. Hossain MZ, Jagdale AB, Ao P, Kazlauskas A, Boynton AL. Disruption of gap junctional communication by the platelet-derived growth factor is mediated via multiple signaling pathways. J Biol Chem. 1999;274:10489-10496.
42. Hossain MZ, Jagdale AB, Ao P, Boynton AL. Mitogen-activated protein kinase and phosphorylation of connexin43 are not sufficient for the disruption of gap junctional communication by platelet-derived growth factor and tetradecanoylphorbol acetate. J Cell Physiol. 1999;179:87-96. (Pubitemid 29108929)
43. Hossain MZ, Ao P, Boynton AL. Platelet-derived growth factor-induced disruption of gap junctional communication and phosphorylation of connexin43 involves protein kinase C and mitogen-activated protein kinase. J Cell Physiol. 1998;176:332-341. (Pubitemid 28319716)
44. Moorby C, Patel M. Dual functions for connexins: Cx43 regulates growth independently of gap junction formation. Exp Cell Res. 2001;271:238-248. (Pubitemid 33141205)
45. Moorby CD, Gherardi E. Expression of a cx43 deletion mutant in 3t3 a31 fibroblasts prevents PDGF-induced inhibition of cell communication and suppresses cell growth. Exp Cell Res. 1999;249:367-376. (Pubitemid 29397944)
46. Horiba M, Kadomatsu K, Nakamura E, Muramatsu H, Ikematsu S, Sakuma S, Hayashi K, Yuzawa Y, Matsuo S, Kuzuya M, Kaname T, Hirai M, Saito H, Muramatsu T. Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest. 2000;105:489-495. (Pubitemid 30127249)
47. Rajagopal V, Rockson SG. Coronary restenosis: a review of mechanisms and management. Am J Med. 2003;115:547-553. (Pubitemid 37352801)
48. Wang L, Chen J, Sun Y, Zhang F, Zhu J, Hu S, Wang DH. Regulation of connexin expression after balloon injury: possible mechanisms for antiproliferative effect of statins. Am J Hypertens. 2005;18:1146-1153.
49. Gennaro G, Menard C, Giasson E, Michaud SE, Palasis M, Meloche S, Rivard A. Role of p44/p42 map kinase in the age-dependent increase in vascular smooth muscle cell proliferation and neointimal formation. Arterioscler Thromb Vasc Biol. 2003;23:204-210. (Pubitemid 36231929)
50. Tanaka K, Hayashi K, Shingu T, Kuga Y, Nomura K, Kajiyama G. Probucol inhibits neointimal formation in carotid arteries of normocholesterolemic rabbits and the proliferation of cultured rabbit vascular smooth muscle cells. Cardiovasc Drugs Ther. 1998;12:19-28. (Pubitemid 28190833)
51. Chang MW, Barr E, Lu MM, Barton K, Leiden JM. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest. 1995;96:2260-2268.
52. Liao Y, Regan CP, Manabe I, Owens GK, Day KH, Damon DN, Duling BR. Smooth muscle-targeted knockout of connexin43 enhances neointimal formation in response to vascular injury. Arterioscler Thromb Vasc Biol. 2007;27:1037-1042. (Pubitemid 46641989)
53. Palatinus JA, Rhett JM, Gourdie RG. The connexin43 carboxyl terminus and cardiac gap junction organization. Biochim Biophys Acta. 2011; In press.
54. Giepmans BN, Verlaan I, Moolenaar WH. Connexin-43 interactions with zo-1 and alpha-and beta-tubulin. Cell Commun Adhes. 2001;8:219-223.
55. Giepmans BN. Gap junctions and connexin-interacting proteins. Cardiovasc Res. 2004;62:233-245. (Pubitemid 38496537)
56. Wu YJ, Sala-Newby GB, Shu KT, Yeh HI, Nakayama KI, Nakayama K, Newby AC, Bond M. S-phase kinase-associated protein-2 (skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo. J Vasc Surg. 2009;50:1135-1142.
57. Sorgen PL, Duffy HS, Sahoo P, Coombs W, Delmar M, Spray DC. Structural changes in the carboxyl terminus of the gap junction protein connexin43 indicates signaling between binding domains for c-Src and zonula occludens-1. J Biol Chem. 2004;279:54695-54701. (Pubitemid 40053213)